SCHEMBL7652610

SCHEMBL7652610

[CH2]CCc1ccccc1CCC

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADRA2B P18089 3/20 0.39
ADRA2C P18825 3/20 0.39
ADRA2A P08913 2/20 0.39
LIPG Q9Y5X9 1/20 0.36
HTR1A P08908 2/20 0.35
PPARG P37231 1/20 0.35
PPARA Q07869 1/20 0.35
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
TAAR1 Q96RJ0 1/20 0.33
NISCH Q9Y2I1 1/20 0.33
DAO P14920 1/20 0.33
CYP4F2 P78329 1/20 0.32
CYP4A11 Q02928 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB2 P47870 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29488434 0.87 ADRA2B (0.44) ADRA2BADRA2CADRA2ALIPGHTR1A
SCHEMBL142479 0.87 ADRA2B (0.44) ADRA2BADRA2CADRA2ALIPGHTR1A
SCHEMBL10497552 0.86 LIPG (0.47) LIPG
SCHEMBL7648927 0.86 LIPG (0.42) ADRA2BADRA2CADRA2ALIPGHTR1A
SCHEMBL6397646 0.85 GABRA1 (0.42) TAAR1CYP4F2CYP4A11GABRA1GABRB2
SCHEMBL321423 0.85 ADRA2B (0.39) ADRA2BADRA2CADRA2ALIPGHTR1A
SCHEMBL7852166 0.84 LIPG (0.55) LIPGPPARGPPARA
SCHEMBL7655901 0.84 CNR2 (0.40) KDM4EALDH1A1GAAHPGD
SCHEMBL7648157 0.84 LIPG (0.46) ADRA2BADRA2CADRA2ALIPGPPARG
SCHEMBL9839840 0.84 ADRA2B (0.43) ADRA2BADRA2CADRA2ALIPGHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109651078-A A kind of preparation method of the anti-form-1-of high-purity (the fluoro- 4- propylcyclohexyl of 2,2- bis-)-4- propylbenzene 黄冈鲁班药业股份有限公司 2019-04-19 CN claimed
US-11718758-B2 Aqueous dispersion of colored particles MITSUBISHI PENCIL COMPANY, LIMITED (JP) 2023-08-08 US disclosed
EP-3725854-B1 COLORED PARTICLE AQUEOUS DISPERSION MITSUBISHI PENCIL CO (JP) 2023-07-05 EP disclosed
US-20210071006-A1 AQUEOUS DISPERSION OF COLORED PARTICLES MITSUBISHI PENCIL COMPANY, LIMITED (JP) 2021-03-11 US disclosed
EP-3725854-A1 COLORED PARTICLE AQUEOUS DISPERSION MITSUBISHI PENCIL COMPANY, LIMITED (JP) 2020-10-21 EP disclosed
US-10451967-B2 Acid- and radical-generating agent and method for generating acid and radical FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2019-10-22 US disclosed
CN-109651078-A A kind of preparation method of the anti-form-1-of high-purity (the fluoro- 4- propylcyclohexyl of 2,2- bis-)-4- propylbenzene 黄冈鲁班药业股份有限公司 2019-04-19 CN disclosed
EP-3444304-A1 POLYFUNCTIONAL POLYMERIZABLE COMPOUND AND COLORED COMPOSITION FUJIFILM Wako Pure Chemical Corporation (JP) 2019-02-20 EP disclosed
CN-105764885-B The production method of acid and free-radical generating agent and acid and free radical 富士胶片和光纯药株式会社 2018-11-09 CN disclosed
US-20160342084-A1 ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2016-11-24 US disclosed
US-6492364-B1 Triazolo and derivatives as chemokine inhibitors TORAY INDUSTRIES, INC. (JP) 2002-12-10 US disclosed
EP-1067130-A1 TRIAZOLO DERIVATIVES AND CHEMOKINE INHIBITORS CONTAINING THE SAME AS THE ACTIVE INGREDIENT TORAY INDUSTRIES, INC. (JP) 2001-01-10 EP disclosed
US-5116858-A Learning enhancement MITSUBISHI KASEI CORPORATION (JP) 1992-05-26 US disclosed
EP-0396973-A1 4-Imidazoline derivatives and their use in preparing pharmaceutical compositions MITSUBISHI KASEI CORPORATION (JP) 1990-11-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10451967-B2 Acid- and radical-generating agent and method for generating acid and radical CBR1, HAO2, CBR3 ADRA2B 1291/4885ADRA2C 1281/4885ADRA2A 476/4885
US-20160342084-A1 ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL CBR1, HAO2, CBR3 ADRA2B 1291/4885ADRA2C 1281/4885ADRA2A 476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.